Thoratec Presentation At Piper Jaffray 24th Annual Healthcare Conference To Be Webcast

Thoratec Presentation At Piper Jaffray 24th Annual Healthcare Conference To Be
                                   Webcast

PR Newswire

PLEASANTON, Calif., Nov. 21, 2012

PLEASANTON, Calif., Nov. 21, 2012 /PRNewswire/ -- Thoratec Corporation
(NASDAQ: THOR), a world leader in device-based mechanical circulatory support
therapies to save, support and restore failing hearts, said today it will be
participating in the Piper Jaffray 24^th Annual Healthcare Conference on
Tuesday, November 27.

Gary F. Burbach, President and Chief Executive Officer, will provide an update
on the company, beginning at 9:00 a.m., Eastern Standard Time (6:00 a.m.,
Pacific Standard Time). The presentation will be available through the
conference web site at http://www.media-server.com/m/p/5xdgn4c3, or on the
company's web site at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heart
failure. The company's products include the HeartMate® LVAS (Left Ventricular
Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than
20,000 devices implanted in patients suffering from heart failure. Thoratec
also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product
lines. Thoratec is headquartered in Pleasanton, California. For more
information, visit the company's website at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered
trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec
Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC,
and PediVAS is a registered trademark of Thoratec Switzerland GmbH.

SOURCE Thoratec Corporation

Website: http://www.thoratec.com
Contact: Taylor Harris, Vice President and Chief Financial Officer, Thoratec
Corporation, +1-925- 738-0047
 
Press spacebar to pause and continue. Press esc to stop.